What is the appropriate action for an alert female patient with a history of severe Multiple Sclerosis (MS) and recently diagnosed End-Stage Renal Disease (ESRD), who has a Do Not Resuscitate (DNR) order and presents with hyperkalemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Hyperkalemia in an Alert ESRD Patient with DNR Status

Dialysis should be offered to this patient immediately, as a DNR order does not preclude dialysis or other life-sustaining treatments—it only addresses resuscitation in the event of cardiopulmonary arrest. 1

Understanding DNR vs. Treatment Limitations

A DNR order is not equivalent to withholding all medical interventions. The distinction is critical:

  • DNR specifically means: No chest compressions, no defibrillation, and no intubation for cardiopulmonary arrest 1
  • DNR does NOT mean: Withholding dialysis, medications, procedures, or other medical treatments 1
  • This patient is alert and has decision-making capacity, which means she can consent to or refuse specific treatments independently 1

Immediate Management of Hyperkalemia

Dialysis is the definitive treatment for hyperkalemia in ESRD patients and should be offered urgently given the potassium level of 6.0 mEq/L. 2, 3

Acute Stabilization Measures (while arranging dialysis):

  • Intravenous calcium to stabilize the myocardium and prevent cardiac arrhythmias 2
  • Intravenous insulin with dextrose to shift potassium intracellularly 2
  • Nebulized albuterol for additional intracellular potassium shifting 2
  • Obtain ECG to assess for hyperkalemia-related cardiac changes, as 36.7% of severe hyperkalemia cases show typical ECG findings 4

Shared Decision-Making Process

The patient must be fully informed about her treatment options through shared decision-making, which is the standard of care for ESRD patients: 1

Required Discussion Points:

  • Prognosis and life expectancy with and without dialysis 1
  • Available treatment options: hemodialysis, peritoneal dialysis, conservative management, or time-limited trial of dialysis 1
  • Risks of untreated hyperkalemia: cardiac arrhythmias, cardiac arrest, and death (mortality rate of 30.7% with severe hyperkalemia) 4
  • Quality of life implications of each option 1

Patient Autonomy:

  • If the patient consents to dialysis, proceed immediately 1
  • If the patient refuses dialysis after being fully informed, her decision must be respected as she has decision-making capacity 1
  • The DNR order remains in effect regardless of whether she accepts dialysis 1

Common Pitfalls to Avoid

Do NOT assume DNR means "do not treat"—this is a fundamental misunderstanding that can lead to inappropriate withholding of beneficial interventions. 1

Do NOT seek consent from family members when the patient is alert and has decision-making capacity—this violates patient autonomy. 1

Do NOT reverse the DNR order to provide dialysis—these are separate decisions. 1

If Dialysis is Declined

Should the patient refuse dialysis after informed consent, palliative care must be provided: 1

  • Hospice involvement for symptom management and end-of-life care 5
  • Symptom control using validated tools (ESAS-R or iPOS-R) 5
  • Continued medical management of hyperkalemia symptoms with medications adjusted for renal function 5
  • Bereavement support for family members 1

Documentation Requirements

Document the following in the medical record: 1

  • Discussion of prognosis, treatment options, and patient's understanding
  • Patient's decision regarding dialysis (acceptance or refusal)
  • Confirmation that DNR status remains unchanged
  • Date and time of all discussions

The correct answer is A: Dialysis is possible without reversal of DNR, though the phrasing is imprecise—dialysis requires patient consent, not DNR reversal, as these are independent decisions.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of hyperkalemia in dialysis patients.

Seminars in dialysis, 2007

Guideline

Hospice Care for End-Stage Renal Disease (ESRD) Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Can losartan be given in patients with End-Stage Renal Disease (ESRD)?
Can a patient with persistent hyperkalemia be kept for observation until the next dialysis session?
What is not an indication for dialysis among hyperkalemia, metabolic acidosis, and impaired renal function (Creatinine (CR) greater than 3 or Blood Urea Nitrogen (BUN) greater than 100)?
Can eating fruits increase potassium levels in dialysis patients?
What is the cause of death in a patient with end-stage renal disease (ESRD) secondary to diabetic kidney disease (DKD), presenting with anasarca, sudden onset hypotension, impaired renal function, hyperkalemia, and leukocytosis?
How do you wean a patient with Raynaud's phenomenon off beta-blockers (beta-adrenergic blocking agents)?
What oral antibiotics can be used to step down treatment for a patient with pneumonia and pleural effusion after initial treatment with Ceftriaxone (Cephalosporin antibiotic)?
What is a suitable weight-neutral antidepressant option for a patient with bipolar disorder and Attention Deficit Hyperactivity Disorder (ADHD), currently taking Adderall (amphetamine) 25mg Extended Release (XR) and Vraylar (cariprazine) 1.5mg, who experiences anxiety and irritability?
What are the considerations for a patient seeking regenerative medicine (medicina regenerativa) treatment for a medical condition, such as musculoskeletal injuries or degenerative diseases?
When should statin (HMG-CoA reductase inhibitor) therapy be initiated in a patient with hyperlipidemia and what are the contraindications for statin initiation?
What is the recommended management for a patient with a high lipid profile based on the Malaysia Clinical Practice Guidelines (CPG)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.